Tyrrell, D. Lorne

About Me


Lorne Tyrrell is a Professor of Medical Microbiology and Immunology at the University of Alberta and served for 10 years as Dean of the Faculty of Medicine and Dentistry until 2004. He currently holds the ClHR/GSK Chair in Virology at the University of Alberta. In 1986, with Dr. Morris Robins, he began working on a system to identify potent antivirals against hepatitis B virus (HBV) which infects about 400 million people worldwide. Through their work they discovered several potent antivirals against HBV and this resulted in a major collaboration with Glaxo Canada (now GlaxoSmithKline). The collaboration led to the discovery that lamivudine had potent antiviral activity for HBV and today lamivudine is licensed worldwide as the first oral antiviral for the treatment of HBV infections. Dr. Tyrrell was appointed to the Alberta Order of Excellence in 2000, an Officer of the Order of Canada in 2002, a Fellow of the Royal Society of Canada in 2004, and received the F.N.G. Starr Award from the Canadian Medical Association in 2004 and And the principal award of the Manning Foundation for his work on antivirals for HBV

Other Details


Category:
Degrees / degrés: